Summary of structure-activity relationships (SAR - PowerPoint PPT Presentation

About This Presentation
Title:

Summary of structure-activity relationships (SAR

Description:

Summary of structure-activity relationships (SAR s) What structural elements are necessary for activity? Removing the oxide bridge (and hydrogenating double bond ... – PowerPoint PPT presentation

Number of Views:313
Avg rating:3.0/5.0
Slides: 34
Provided by: JohnBu154
Learn more at: https://s2.smu.edu
Category:

less

Transcript and Presenter's Notes

Title: Summary of structure-activity relationships (SAR


1
Summary of structure-activity relationships
(SARs)
2
What structural elements are necessary for
activity?
3
Removing the oxide bridge (and hydrogenating
double bond, removing one alcohol) produces
levorphanol, which has enhanced analgesic
properties over morphine.
Levorphanol is used to treat severe pain and has
several brand names.
4
Generic Name Levorphanol Brand Names/Synonyms Ant
algin Aromarone Cetarin Dea No. 9220 Dea No.
9733 Dromoran Lemoran Levo-Dromoran Levorfanol
Inn-Spanish Levorfanolo Dcit Levorphan Levorph
anal Levorphanol Dl-Form Levorphanol
Tartrate Levorphanolum Inn-Latin Methorfinan
Czech Methorphinan Orphan Racemethorphanum Racem
ic Dromoran Racemorfano Inn-Spanish Racemorphan
Racemorphan BanInn Racemorphane
Inn-French Racemorphanum Inn-Latinanum
Inn-Latin
5
Surprisingly, its mirror image still has
antitussive properties, but no analgesic
properties
6
Methylating the phenolic hydroxyl group improves
this antitussive activity
7
Dextromethorphan (DM or DXM) is an antitussive
drug that is found in many over-the-counter cold
and cough preparations, usually in the form of
dextromethorphan hydrobromide. It is also
commonly taken above the recommended dosage by
users seeking its dissociative effect.
  • The FDA has approved dextromethorphan for
    over-the-counter sale as a cough suppressant. A
    combination of dextromethorphan and quinidine has
    been shown to alleviate symptoms of easy laughing
    and crying (pseudobulbar affect) in patients with
    amyotrophic lateral sclerosis and multiple
    sclerosis.3
  • Dextromethorphan is being investigated as a
    possible treatment for pain associated with
    fibromyalgia, a chronic rheumatological organic
    fatigue disorder.4
  • Dextromethorphan is also useful in breaking
    addictions to narcotics and other habit-forming
    drugs (including nicotine), since it is an
    inhibitor of many of the brain receptors involved
    in narcotic action on the brain. For this
    purpose, DXM is more effective when combined with
    an oxidase inhibitor, which suppresses its
    inactivation and increases its half-life thus it
    increases the concentration of DXM in the
    circulating blood and extends its effective
    duration.5

8
(No Transcript)
9
Meperidine
  • Pethidine (INN) or meperidine (USAN) (also
    referred to as isonipecaine lidol pethanol
    piridosal Algil? Alodan? Centralgin?
    Demerol? Dispadol? Dolantin? Dolargan? (in
    Poland)1 Dolestine? Dolosal? Dolsin?
    Mefedina?) is a fast-acting opioid analgesic
    drug. In the United States, it is more commonly
    known as meperidine or by its brand name
    Demerol.2Pethidine is indicated for the
    treatment of moderate to severe pain, and is
    delivered as its hydrochloride salt in tablets,
    as a syrup, or by intramuscular or intravenous
    injection.

10
Meperidine
  • For much of the 20th century, pethidine was the
    opioid of choice for many physicians in 1983 60
    of doctors prescribed it for acute pain and 22
    for chronic severe pain.3 Compared to morphine,
    pethidine was supposed to be safer and carry less
    risk of addiction, and to be superior in treating
    the pain associated with biliary spasm or renal
    colic due to its putative antispasmodic effects.
    In fact, pethidine is no more effective than
    morphine at treating biliary or renal pain, and
    its low potency, short duration of action, and
    unique toxicity (i.e. seizures, delirium, other
    neuropsychological effects) relative to other
    available opioid analgesics have seen it fall out
    of favor in recent years, for all but a very few,
    very specific indications. Several countries,
    including Australia, have put severe limits on
    its use or curtailed it outright.4
    Nevertheless, some physicians continue to use it
    as a first-line strong opioid.

11
Opioids to treat diarrhea?
12
Diphenoxylate
  • Diphenoxylate is an opioid agonist used for the
    treatment of diarrhea that acts by slowing
    intestinal contractions. It was discovered at
    Janssen Pharmaceutica in 1956. It is a congener
    to the narcotic Meperidine of which the common
    brand name is Demerol. This being the case, this
    medication is potentially habit-forming,
    particularly in high doses or when long-time
    usage is involved. Because of this, diphenoxylate
    is manufactured and marketed as a combination
    drug with atropine (Lomotil?).

13
Lomotil
  • This pharmaceutical strategy is designed to
    discourage abuse, because the anticholinergic
    effect of atropine will produce severe weakness
    and nausea if standard dosage is exceeded.
  • Tablets - round, white, with SEARLE debossed on
    one side and 61 on the other side and containing
    2.5 mg of diphenoxylate hydrochloride and 0.025
    mg of atropine sulfate,

14
Loperamide (Imodium)
  • Loperamide is an opioid receptor agonist and acts
    on the µ-opioid receptors in the myenteric plexus
    large intestines it does not affect the central
    nervous system like other opioids.

15
Loperamide (Imodium)
  • It works by decreasing the activity of the
    myenteric plexus which decreases the motility of
    the circular and longitudinal smooth muscles of
    the intestinal wall. This increases the amount of
    time substances stay in the intestine, allowing
    for more water to be absorbed out of the fecal
    matter. Loperamide also decreases colonic mass
    movements and suppresses the gastrocolic
    reflex.1

16
Loperamide (Imodium)
  • Loperamide does not cross the blood-brain barrier
    and has no analgesic properties. Tolerance in
    response to long-term use has not been
    reported.However, loperamide can cause physical
    dependence. Symptoms of opiate withdrawal have
    been observed in patients abruptly discontinuing
    long-term therapy with loperamide.

17
Fentanyl
18
Fentanyl
  • Fentanyl is an opioid analgesic, first
    synthesized by Janssen Pharmaceutica (Belgium) in
    the late 1950s, with an analgesic potency of
    about 80 times that of morphine. Fentanyl was
    introduced into medical practice in the 1960s as
    an intravenous anesthetic under the trade name of
    Sublimaze.

19
Fentanyl analogs
20
Fentanyl and analogs
  • Fentanyls are extensively used for anesthesia and
    analgesia, most often in the operating room and
    intensive care unit. Duragesic, by Janssen
    Pharmaceutica, is a fentanyl transdermal patch
    used in chronic pain management. Duragesic
    patches work by releasing fentanyl into body
    fats, which then slowly release the drug into the
    blood stream over 72 hours, allowing for long
    lasting relief from pain.

21
Carfentanil
  • Carfentanil was discovered by Janssen
    Pharmaceutica. It has a quantitative potency
    approximately 10,000 times that of morphine and
    100 times that of fentanyl, activity in humans
    starting at about 1 µg. It is marketed under the
    trade name Wildnil as a tranquilizer for large
    animals.1 Carfentanil is intended for animal
    use only as its extreme potency makes it
    inappropriate for use in humans.

22
Carfentanil
  • It is thought that in the 2002 Moscow theater
    hostage crisis, the Russian military made use of
    an aerosol form of carfentanil to subdue Chechen
    hostage takers.2 Its short action, easy
    reversibility and therapeutic index (10600 vs.
    300 for fentanyl) would make it a near-perfect
    agent for this purpose.

23
Carfentanil
  • Wax et al. surmise from the available evidence
    that the Moscow emergency services had not been
    informed of the use of the agent, and therefore
    did not have adequate supplies of naloxone or
    naltrexone (opioid antagonists) to prevent
    complications in many of the victims. Assuming
    that carfentanil was the only active constituent
    (which has not been verified by the Russian
    military), the primary acute toxic effect to the
    theatre victims would have been opioid-induced
    apnea in this case mechanical ventilation and/or
    treatment with opioid antagonists would have been
    life-saving for many or all victims.

24
Methadone
25
Methadone
  • Methadone/dolophine, was first synthesized in
    1937 by German scientists Max Bockm?l and Gustav
    Ehrhart at IG Farben (Hoechst-Am-Main, now part
    of Frankfurt, Germany) during their search for an
    analgesic that would be easier to use during
    surgery (and less potentially addictive, post-op)
    than morphine.

26
Methadone
  • Methadone was introduced into the United States
    in 1947 by Eli Lilly and Company as an analgesic
    (They gave it the trade name Dolophine?, which is
    now registered to Roxane Laboratories). Since
    then, it has been best known for its use in
    treating narcotic addiction, although such a use
    never became widespread and common until the
    early 1990's when public policy sought to find
    ways to reduce the spread of HIV and AIDS.

27
Scheduling of Drugs
  • Drugs are classified or scheduled depending on
    their potential for abuse and whether or not
    there is a medical need for a particular drug.

28
Schedule I drugs
  • Findings required
  • (A) The drug or other substance has a high
    potential for abuse.
  • (B) The drug or other substance has no currently
    accepted medical use in treatment in the United
    States.
  • (C) There is a lack of accepted safety for use of
    the drug or other substance under medical
    supervision.
  • Examples include Heroin, Cannabis, and LSD

29
Schedule II drugs
  • Findings required
  • The drug or other substance has a high potential
    for abuse.
  • The drug or other substance has a currently
    accepted medical use in treatment in the United
    States or a currently accepted medical use with
    severe restrictions.
  • Abuse of the drug or other substances may lead
    to severe psychological or physical dependence.
  • Examples include Morphine, Cocaine,
    Methylphenidate (Ritalin)

30
Schedule III drugs
  • Findings required
  • (A) The drug or other substance has a potential
    for abuse less than the drugs or other substances
    in schedules I and II.
  • (B) The drug or other substance has a currently
    accepted medical use in treatment in the United
    States.
  • (C) Abuse of the drug or other substance may lead
    to moderate or low physical dependence or high
    psychological dependence.
  • Examples include anabolic steroids, hydrocodone,
    and codeine.

31
Schedule IV drugs
  • Findings required
  • (A) The drug or other substance has a low
    potential for abuse relative to the drugs or
    other substances in schedule III.
  • (B) The drug or other substance has a currently
    accepted medical use in treatment in the United
    States.
  • (C) Abuse of the drug or other substance may lead
    to limited physical dependence or psychological
    dependence relative to the drugs or other
    substances in schedule III.
  • Examples include benzodiazepines and barbituates.

32
Schedule V drugs
  • Findings required
  • (A) The drug or other substance has a low
    potential for abuse relative to the drugs or
    other substances in schedule IV.
  • (B) The drug or other substance has a currently
    accepted medical use in treatment in the United
    States.
  • (C) Abuse of the drug or other substance may lead
    to limited physical dependence or psychological
    dependence relative to the drugs or other
    substances in schedule IV.
  • Examples include cough syrups containing a small
    amount of codeine, or anti-diarrheals containing
    small amounts of diphenoxylate.

33
Introduction to influenza
  • http//microbiology.mtsinai.on.ca/sarswatch/presen
    tations/index.asp
  • http//www.pharmasquare.org/flash/Tamiflu.html
Write a Comment
User Comments (0)
About PowerShow.com